Abstract: 3,20-dione-11.beta.-hydroxypregn-4-ene-21-thioacetate-17-butyrate and 3,20-dione-11.beta.-hydroxypregn-4-ene-21-thiopropionate-17-butyrate, are anti-inflammatory agents.
Type:
Grant
Filed:
November 4, 1985
Date of Patent:
June 12, 1990
Assignee:
Jouveinal, S.A.
Inventors:
Gilbert G. Aubard, Agnes G. Grouhel, Jean-Louis Junien, Claude P. Roux, Dieran R. Torossian
Abstract: Pharmaceutical preparation and method for percutaneous treatment of edemas, with the pharmaceutical preparation comprising an active element consisting of acetazolamide in a concentration of between 1 to 50% incorporated in a vehicle which is compatible with percutaneous administration.
Type:
Grant
Filed:
May 24, 1971
Date of Patent:
January 20, 1976
Assignee:
Jouveinal, S.A.
Inventors:
Claude Paul Roux, Dieran Robert Torossian